Medpace MEDP
Jump To Section
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Medpace (MEDP) Business Model and Operations Summary
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Key Insights
Medpace (MEDP) Core Market Data and Business Metrics
Latest Closing Price
$447.92Market Cap
$13.22 BillionAverage Daily Volume
423,545.5 Shares52-Week Range
$250.05-$500.82Price-Earnings Ratio
33.25Total Outstanding Shares
28.09 Million SharesCEO
August James TroendleTotal Employees
6,000Current Dividend
No dividendIPO Date
August 11, 2016SIC Description
Services-commercial Physical & Biological ResearchHeadquarters
5375 Medpace Way, Cincinnati, OH, 45227